# Bacterial Decolonization to Prevent Radiation Dermatitis

> **NCT03883828** · PHASE2,PHASE3 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Radiation Dermatitis

## Interventions

- **DRUG:** Chlorhexidine gluconate solution
- **DRUG:** Mupirocin Ointment

## Key facts

- **NCT ID:** NCT03883828
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-03
- **Primary completion:** 2021-12-02
- **Final completion:** 2021-12-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883828, "Bacterial Decolonization to Prevent Radiation Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03883828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*